Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 2

Results For "invasive"

288 News Found

Dr. Reddy's rolls out drug-free non-invasive migraine management device ‘Nerivio’ in India
News | November 17, 2023

Dr. Reddy's rolls out drug-free non-invasive migraine management device ‘Nerivio’ in India

Nerivio is a prescription-based non-invasive device intended for acute and prophylactic (preventive) treatment of migrain


Apollo Hospitals Navi Mumbai performs first minimally invasive mitral heart valve replacement
Healthcare | July 05, 2022

Apollo Hospitals Navi Mumbai performs first minimally invasive mitral heart valve replacement

Transcatheter Mitral valve procedure allows intervention on patients who are unsuitable or high risk for open heart surgery


Non-invasive leadless pacemaker implanted in a 60-year-old at Fortis Hospital, Malar
Hospitals | March 10, 2022

Non-invasive leadless pacemaker implanted in a 60-year-old at Fortis Hospital, Malar

The medical team led by Dr. Babu Ezhumalai implanted the dual-chamber leadless pacemaker through a non-surgical procedure successfully


VivaLyf Innovations to launch EzLyf, India's first non-invasive glucometer
Startup | December 30, 2021

VivaLyf Innovations to launch EzLyf, India's first non-invasive glucometer

The glucometer connects to one’s smartphone and provides actionable diagnostic information


ImmunityBio scores first Asian approval for ANKTIVA in Macau
News | March 25, 2026

ImmunityBio scores first Asian approval for ANKTIVA in Macau

The Macau authorization followed a regulatory review that considered prior decisions by both the US FDA) and the European Medicines Agency


Siemens Healthineers expands radiotherapy beyond cancer, targets osteoarthritis pain
News | March 25, 2026

Siemens Healthineers expands radiotherapy beyond cancer, targets osteoarthritis pain

The radiotherapy systems include TrueBeam, TrueBeam STx, VitalBeam, and Edge


Johnson & Johnson reports promising early results for targeted bladder cancer therapy
Clinical Trials | March 17, 2026

Johnson & Johnson reports promising early results for targeted bladder cancer therapy

FGFR alterations are prevalent in early-stage bladder cancer, appearing in roughly 70% of intermediate-risk and 40% of high-risk NMIBC tumors


Fortis launches 4 specialized clinics in Bengaluru to tackle under-discussed health issues
Hospitals | March 12, 2026

Fortis launches 4 specialized clinics in Bengaluru to tackle under-discussed health issues

The new facilities are designed to provide focused, patient-centric care through advanced diagnostics, minimally invasive treatments, and multidisciplinary expertise